Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International Journal of Cancer ; 129 (2011), 2. - S. 407-416. - ISSN 0020-7136. - eISSN 1097-0215
- Schlagwort
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Ereignis
-
Veröffentlichung
- (wo)
-
Konstanz
- (wer)
-
Bibliothek der Universität Konstanz
- (wann)
-
2012
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bsz:352-163157
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Müller, Marc
- Schlosser, Eva Christine
- Gander, Bruno
- Groettrup, Marcus
- Bibliothek der Universität Konstanz
Entstanden
- 2012
Ähnliche Objekte (12)
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection
Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS) : Mediated Anti-tumor Therapy
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
PLGA Particles in Immunotherapy
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection
Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS) : Mediated Anti-tumor Therapy
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
PLGA Particles in Immunotherapy
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection
Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS) : Mediated Anti-tumor Therapy
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
PLGA Particles in Immunotherapy
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation